Dr. Nevena Damjanov, MD
- Medicare services, 2024
- 264
- Medicare patients, 2024
- 50
- Part D claims, 2024
- 110
- Publications
- 49
- Clinical trials
- 2
- Practice address
- 51 North 39th Street, Philadelphia, PA 19104
- Practice phone
- Call (215) 662-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Damjanov's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Nevena Damjanov is a hematologist and oncologist in Philadelphia, Pennsylvania
Dr. Damjanov practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.
Dr. Damjanov's NPI, 1518954395, was assigned on October 5, 2005. Dr. Damjanov graduated from Drexel University College Of Medicine in 1989. Dr. Damjanov holds Pennsylvania license MD045158L.
- NPI
- 1518954395NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2466357249
- NPI enumeration date
- October 5, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (215) 662-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 63
- Medical school graduation
- 1989
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Nevena Damjanov practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania
Dr. Damjanov's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.
- Penn Presbyterian Medical Center51 North 39th Street, Philadelphia, PA 19104 · Philadelphia CountyPhone(215) 662-8000
Source: Dmand AI Affiliation Data
Dr. Nevena Damjanov is affiliated with 2 sites of care and 1 medical group
Dr. Damjanov's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Damjanov is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Nevena Damjanov's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Damjanov practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Penn Presbyterian Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Pennsylvania and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Nevena Damjanov is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Damjanov's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Damjanov is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Damjanov's licenses on file in 2 states: Pennsylvania and Ohio.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
- Ohio license
Clinical focus
Dmand AI lists chronic anemia, colorectal cancer and lung cancer among the conditions Dr. Damjanov treats.
Hematologists and oncologists near Dr. Damjanov
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Nevena Damjanov billed Medicare for 264 services in 2024
CMS data shows 264 Medicare services from Dr. Damjanov across 3 procedure codes in 2024, for 50 Medicare patients. Medicare paid $14,861 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Damjanov's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 02024: 154
- Office and hospital visits
- 2023: 1062024: 1104%
Dr. Damjanov compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Damjanov
- Pennsylvania median
- Medicare services
- 264vs 65460% below
- Medicare patients
- 50vs 22778% below
- Part D claims
- 16vs 39396% below
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Damjanov's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Damjanov?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Damjanov and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Nevena Damjanov treated 50 Medicare patients in 2024, average age 72
CMS counts 50 Medicare patients who saw Dr. Damjanov in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Damjanov's median patient age at 71, with 51% women.
Dr. Damjanov's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Damjanov's Medicare patients by sex, 2024
- Women2040%
- Men3060%
Chronic conditions among Dr. Damjanov's Medicare patients, 2024
- High blood pressure75%
- High cholesterol74%
- Cancer46%
- Diabetes46%
- Arthritis40%
- Anxiety34%
- Chronic kidney disease26%
- Ischemic heart disease26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Damjanov's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women51%
- Men49%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Nevena Damjanov wrote 110 Medicare Part D claims in 2024
In 2024, Dr. Damjanov wrote 110 Medicare Part D claims for 34 patients. 95% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $231 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.
Dr. Damjanov's Part D claims by kind of drug, 2024
- Generic105 claims95%
- Brand-name and other5 claims5%
Dr. Damjanov's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Damjanov's Part D claims, 2024
- Opioids14%15 of 110 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 262024: 1638%
Drugs named by CMS: 1 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Nevena Damjanov scored 85 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Damjanov for performance year 2024, reported as part of a group. Dr. Damjanov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Damjanov as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Damjanov's MIPS scores, performance year 2024
- 85of 100Final score
- 73.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 76of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Nevena Damjanov has 49 publications on record
Dmand AI links 49 papers to Dr. Damjanov, published from 2009 to 2024. 2017 was the busiest year, with 9. The most frequent topics are Liver Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Damjanov has published most often in Oncology (Williston Park). Dr. Damjanov's most frequent co-authors are Andrew D. Rhim, MD, Ursina R. Teitelbaum, MD and Bonnie Ky, MD.
Dr. Damjanov's papers by year, 2013 to 2024
Topics Dr. Damjanov writes about most
- Liver Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Chemoradiotherapy
- Carcinoma, Hepatocellular
- Cholangiocarcinoma
- Colonic Neoplasms
- Paclitaxel
Dr. Damjanov's most frequent co-authors
- Andrew D. Rhim, MD8 shared papers
- Ursina R. Teitelbaum, MD7 shared papers
- Bonnie Ky, MD6 shared papers
Recent publications by Dr. Damjanov
Cardiovasc Intervent Radiol
See who Dr. Damjanov researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Damjanov works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Nevena Damjanov has worked on 2 clinical trials
Dmand AI links Dr. Damjanov to 2 clinical trials. Conditions studied include Carcinoma, Hepatocellular, Rectal Neoplasms and Colonic Neoplasms. Abramson Cancer Center at Penn Medicine sponsors the most, 2.
Clinical trials with Dr. Damjanov by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Damjanov's trials
- Carcinoma, Hepatocellular
- Rectal Neoplasms
- Colonic Neoplasms
- Liver Neoplasms
Investigators on the most trials with Dr. Damjanov
- Ursina R. Teitelbaum, MD2 shared trials
- Ravi K. Amaravadi, MD1 shared trial
- Bruce J. Giantonio, MD1 shared trial
Recent clinical trials with Dr. Damjanov
Phase II Trial of Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Nevena Damjanov received $226,596 in industry payments from 2016 to 2025
CMS Open Payments shows 307 general payments to Dr. Damjanov from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. Sirtex Medical Inc paid the most, $98,290.
General payments to Dr. Damjanov by program year, 2016 to 2025
General payments to Dr. Damjanov by kind, 2016 to 2025
- Consulting fees$91,57540%
- Honoraria$81,50036%
- Travel and lodging$38,69417%
- Speaker and faculty fees$9,1504%
- Other$5,6773%
Companies that paid Dr. Damjanov the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Nevena Damjanov has 1 award and honors on record
Dmand AI lists 1 award for Dr. Damjanov, most recently CMS Stage 1 EHR in 2012.
Awards and honors for Dr. Damjanov
- 2012
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Nevena Damjanov graduated from Drexel University College Of Medicine
Dr. Damjanov graduated from Drexel University College Of Medicine in 1989. Dr. Damjanov is a member of ASCO.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Nevena Damjanov accepts plans from 13 insurance carriers
Dr. Damjanov is in network with 13 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Cigna
- Elevance
- HCSC
- Highmark
- Horizon Blue Cross Blue Shield of New Jersey
- Blue Cross Blue Shield of Massachusetts
- +5 more carriersWith a free account
Plan types Dr. Damjanov accepts, by number of carriers
- PPO10
- HMO8
- Medicare8
- EPO3
- POS3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Nevena Damjanov's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Nevena Damjanov
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Nevena Damjanov's NPI number?
Dr. Nevena Damjanov's NPI number is 1518954395. It was assigned on October 5, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Nevena Damjanov?
Dr. Nevena Damjanov is a hematologist and oncologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Nevena Damjanov practice?
Dr. Damjanov practices at 51 North 39th Street, Philadelphia, PA 19104. Dr. Damjanov's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.
What is Dr. Nevena Damjanov's office phone number?
The practice phone on file for Dr. Damjanov is (215) 662-8000.
What is Dr. Nevena Damjanov's medical license number?
Dr. Damjanov holds Pennsylvania license MD045158L, one of the licenses on file in 2 states.
Which states has Dr. Nevena Damjanov been licensed in?
Dmand AI has state licenses on file for Dr. Damjanov in Pennsylvania (1990 to 2026) and Ohio (1996 to 2007).
Which hospitals is Dr. Nevena Damjanov affiliated with?
Dr. Damjanov practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania. Dr. Damjanov is also affiliated with Hospital of the University of Pennsylvania.
What medical group is Dr. Nevena Damjanov part of?
Dr. Damjanov is linked to Penn Medicine Lancaster General Health.
Does Dr. Nevena Damjanov accept Medicare?
Yes. CMS data shows Dr. Damjanov billed Medicare for 264 services in 2024, and Dr. Damjanov accepts Medicare assignment.
Does Dr. Nevena Damjanov offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Damjanov as offering telehealth services.
Show 11 more questionsShow fewer questions
What is Dr. Nevena Damjanov's MIPS score?
Dr. Damjanov's MIPS final score for performance year 2024 is 85 out of 100, reported as part of a group.
How many Medicare patients does Dr. Nevena Damjanov see?
CMS counts 50 Medicare patients who saw Dr. Damjanov in 2024, with an average age of 72.
Is Dr. Nevena Damjanov board certified?
Yes. Dr. Damjanov is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Nevena Damjanov bill to Medicare?
In 2024, Dr. Damjanov's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and medicare service (G2212).
Where did Dr. Nevena Damjanov go to medical school?
Dr. Damjanov graduated from Drexel University College Of Medicine in 1989.
What drugs does Dr. Nevena Damjanov prescribe most?
In 2024 Medicare Part D data, Dr. Damjanov's most prescribed drugs by claims were Prochlorperazine Maleate.
Has Dr. Nevena Damjanov received payments from drug or device companies?
CMS Open Payments shows $226,596 in general payments to Dr. Damjanov from 22 companies from 2016 to 2025. The largest total came from Sirtex Medical Inc.
How long has Dr. Nevena Damjanov been practicing?
Dr. Damjanov graduated from medical school in 1989, 37 years ago.
Does Dr. Nevena Damjanov do research?
Dmand AI links 49 publications to Dr. Damjanov, published from 2009 to 2024. Dr. Damjanov has worked on 2 clinical trials.
Who does Dr. Nevena Damjanov publish with?
Dr. Damjanov's most frequent co-authors are Andrew D. Rhim, MD (8 shared papers), Ursina R. Teitelbaum, MD (7 shared papers) and Bonnie Ky, MD (6 shared papers).
What insurance does Dr. Nevena Damjanov accept?
Dr. Damjanov is in network with 13 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card